Abstract: The present invention relates to the treatment of myocardial infarction, especially to the reduction of tissue damage, the reduction of infarction scars, the improvement of cardiac function, and/or the prevention of congestive heart failure after myocardial infarction. The invention further relates to WNT antagonists, their use in the treatment of myocardial infarction, and to pharmaceutical compositions comprising WNT antagonists.

Abstract: The invention relates to a method for characterizing a computer program section held in a computer memory system, comprising the steps of breaking down the computer program section into segments, wherein program commands contained in the computer program section are used to define a program flow relationship between the segments, and determining characteristic data which can be associated with the program flow relationship of the segments, wherein the characteristic data are compressed to form a signature which identifies the computer program section.

Abstract: A method of illuminating at least two illumination points by means of at least one spatial light modulator, said at least one spatial light modulator comprising a plurality of light modulators, whereby a predefined amount of energy transmitted to said points is at least partly controlled by varying the number of said light modulators illuminating said point.